Urothelial carcinoma
Conditions
Interventions
Index test:A multi-omics early model based on patient urine mass spectrometry results, serum mass spectrometry results, imaging data, and clinical information
Sponsors
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age = 18 years. 2. Patients diagnosed with urothelial carcinoma or benign urological diseases (including but not limited to urinary calculi, benign prostatic hyperplasia, and benign urological tumors) at multiple centers with Sir Run Run Shaw Hospital as the the leading center, or healthy individuals undergoing routine physical examinations. 3. Voluntary participation in this study with signed informed consent. If a participant is unable to read or sign the informed consent form due to incapacity (e.g., lack of legal competence), their legal guardian must complete the informed consent process and sign on their behalf. If a participant is unable to read the informed consent form (e.g., illiterate participants), the informed consent process must be witnessed by an impartial witness, who will also sign the consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals currently menstruating. 2. Vulnerable populations, excluding critically ill patients/elderly individuals/illiterate individuals/ people with mental illnesses/ people with cognitive impairments/ pregnant women, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Specificity;Sensitivity; | — |
Countries
China
Contacts
Public ContactGuoqing Ding
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Outcome results
None listed